Harvard Bioscience (NASDAQ:HBIO) is a global developer, manufacturer, and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used in life science research. Founded in 1901 at Harvard University Medical School under the name Harvard Apparatus, the company changed the name to Harvard Bioscience in 1996.
With annual revenue of $105 million in 2013, the company sells products in over 100 countries. Headquartered in Massachusetts, the company has manufacturing facilities in the US and Europe with sales offices in Canada, France, and China.
During the past few years, the company has focused on its regenerative business and implemented its internal R&D strategy on re-growing human organs in bio-reactors for life-saving transplantations. In November 4,...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|